首页> 外文期刊>Dermatology: international journal for clinical and investigative dermatology >Hyperkeratosis lenticularis perstans (Flegel's disease)--lack of response to treatment with tacalcitol and calcipotriol.
【24h】

Hyperkeratosis lenticularis perstans (Flegel's disease)--lack of response to treatment with tacalcitol and calcipotriol.

机译:波斯角化病(Flegel's病)-对他钙醇和卡泊三醇的治疗缺乏反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Hyperkeratosis lenticularis perstans (HLP) or Flegel's disease is a rare dermatosis characterized by asymptomatic hyperkeratotic papules predominantly located on the lower extremities. Lesional and non-lesional epidermis samples were studied by light- and electron-microscopic examination. The main ultrastructural finding was the presence of structurally altered Odland bodies/membrane-coating granules. Different therapeutic options for HLP have been reported, but none of the treatments was shown to be consistently effective. Here, we report on a patient with Flegel's disease who did respond to topical 5-fluorouracil, whereas topical vitamin D(3) synthetics were ineffective. Copyright 2001 S. Karger AG, Basel
机译:角膜过度角化病(HLP)或Flegel病是一种罕见的皮肤病,其特征是无症状的过度角化丘疹主要位于下肢。通过光镜和电子显微镜检查研究了病变和非病变表皮样品。主要的超微结构发现是存在结构改变的奥德兰体/膜包衣颗粒。已经报道了HLP的不同治疗选择,但是没有一种疗法被证明是持续有效的。在这里,我们报道了一位确实对局部5-氟尿嘧啶有反应的Flegel病患者,而局部维生素D(3)合成药物无效。版权所有2001 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号